The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of a structured intervention program to improve physical activity (PA) of adolescents and young adult cancer survivors (AYAs): Final results of the randomized Motivate AYA–MAYA trial.
 
Jannike Lisa Salchow
No Relationships to Disclose
 
Wiebke Jensen
No Relationships to Disclose
 
Barbara Koch
No Relationships to Disclose
 
Julia von Grundherr
No Relationships to Disclose
 
Simon Elmers
No Relationships to Disclose
 
Gabriele Escherich
No Relationships to Disclose
 
Rüdiger Reer
No Relationships to Disclose
 
Carsten Bokemeyer
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck KGaA; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AOK Health Insurance; Bayer Schering Pharma; GSO; Hexal; Lilly/ImClone; Merck Serono; Merck Sharp & Dohme; Mundipharma; Sanofi
Research Funding - several companies in coooperation for clincal studies and for preclinical laboratory work (at my institution more than 100 ongoing reserach projects) (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pfizer; Sanofi
 
Julia Mann
No Relationships to Disclose
 
Alexander Stein
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck KGaA; MSD; Roche
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Roche; Sanofi; Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA; Roche